Feuring, M. (2017). Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: Analyses from RE-COVER, RE-COVER II, and RE-MEDY. Journal of thrombosis and thrombolysis, 43(4), . https://doi.org/10.1007/s11239-017-1479-z
Chicago-Zitierstil (17. Ausg.)Feuring, Martin. "Net Clinical Benefit of Dabigatran Vs. Warfarin in Venous Thromboembolism: Analyses from RE-COVER, RE-COVER II, and RE-MEDY." Journal of Thrombosis and Thrombolysis 43, no. 4 (2017). https://doi.org/10.1007/s11239-017-1479-z.
MLA-Zitierstil (9. Ausg.)Feuring, Martin. "Net Clinical Benefit of Dabigatran Vs. Warfarin in Venous Thromboembolism: Analyses from RE-COVER, RE-COVER II, and RE-MEDY." Journal of Thrombosis and Thrombolysis, vol. 43, no. 4, 2017, https://doi.org/10.1007/s11239-017-1479-z.